Direkt zum Inhalt

Gruber, Isabella ; Edinger, Matthias ; Poeck, Hendrik ; Meedt, Elisabeth ; Weber, Daniela ; Holler, Ernst ; Herr, Wolfgang ; Koelbl, Oliver ; Wolff, Daniel

Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning

Artikel

Gruber, Isabella , Edinger, Matthias , Poeck, Hendrik , Meedt, Elisabeth, Weber, Daniela, Holler, Ernst , Herr, Wolfgang , Koelbl, Oliver und Wolff, Daniel (2026) Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning. Supportive Care in Cancer 34 (12).

DOI zum Zitieren dieses Dokuments: 10.5283/epub.83200


Zusammenfassung

Purpose We evaluated the association between total body irradiation (TBI) dose and severe oral mucositis (OM) in adults with acute lymphoblastic leukemia (ALL) undergoing myeloablative allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods We analyzed 101 adults receiving 8 or 12 Gy TBI. Severe OM was defined as WHO grades 3–4. TBI allocation was non-randomized, with 8 Gy more ...

Purpose
We evaluated the association between total body irradiation (TBI) dose and severe oral mucositis (OM) in adults with acute lymphoblastic leukemia (ALL) undergoing myeloablative allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Methods
We analyzed 101 adults receiving 8 or 12 Gy TBI. Severe OM was defined as WHO grades 3–4. TBI allocation was non-randomized, with 8 Gy more frequently used in older patients and those with a Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) > 3. Multivariable logistic regression assessed factors associated with severe OM, with the Karnofsky Performance Status (KPS) included in the primary model; sensitivity analyses evaluated alternative models.
Results
Severe OM occurred in 48 patients (47.5%) and was more frequent after 12 than 8 Gy (62.0% vs. 33.3%, P = 0.005). In the primary model, 12 Gy TBI was associated with higher odds of severe OM (OR 2.78, 95% CI 1.17–6.78; P = 0.022). The association between 12 Gy TBI and severe OM remained significant when HCT-CI replaced KPS and after calendar-year adjustment. After age adjustment, the estimate was similar, but the confidence interval widened and included the null (OR 2.63, 95% CI 0.90–8.06; P = 0.081). Severe OM was associated with a 4-day longer median hospital stay (41 vs. 37 days, P = 0.001) and a 5-day longer median duration of systemic therapeutic antibiotic treatment (20 vs. 15 days, P = 0.002). Neither measure differed significantly by TBI dose.
Conclusion
Higher TBI dose was associated with severe OM; severe OM was associated with longer hospital stays and systemic therapeutic antibiotic treatment. Findings should be interpreted cautiously given non-randomized TBI allocation.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftSupportive Care in Cancer
VerlagSpringer
Open Access ArtDEAL (Springer)
Band34
Nummer des Zeitschriftenheftes oder des Kapitels12
Datum18 November 2026
Veröffentlichungsdatum19 Nov 2026 05:56
InstitutionenMedizin > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medizin > Lehrstuhl für Strahlentherapie
Leibniz-Institut für Immuntherapie (LIT)
Identifikationsnummer
WertTyp
10.1007/s00520-026-11471-7DOI
Stichwörter / KeywordsOral mucositis · Hematopoietic stem cell transplantation · Total body irradiation · Antibiotic therapy · Hospital stay
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenJa
URN der UB Regensburgurn:nbn:de:bvb:355-epub-832000
Dokumenten-ID83200

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben